Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Boston Scientific

Boston Scientific Shows Improved Relative Strength; Still Shy Of Benchmark

Boston Scientific shows improving price performance, earning an upgrade to its IBD Relative Strength Rating

Investors Business Daily

3 Biotech Catalysts Present Major Opportunity

Three promising biotech names stand out for potentially catalyzing drugs currently on the market or in development; here's why they may rally further.

MarketBeat

Uber Leads 5 Stocks Near Buy Points As Market Rebounds

Uber, JPMorgan and RTX are stocks to watch. The market jumped Friday as Fed chief Powell hinted at rate cuts.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Boston Scientific Shows Rising Relative Price Performance; Still Shy Of Key Benchmark

A Relative Strength Rating upgrade for Boston Scientific shows improving technical performance. Will it continue?

Investors Business Daily

Dow Jones Futures Fall Amid Walmart Earnings, Meta News After Palantir-Led Rally Off Lows

The major indexes bounced, but Palantir and many leaders still have sharp weekly losses. Walmart earnings loom.

Investors Business Daily

IBD Stock Of The Day Boston Scientific Flashing Early Buy Signal

Boston Scientific is Wednesday's IBD Stock Of The Day. Shares are breaking a short-term trendline at their 50-day moving average.

Investors Business Daily

IBD Rating Upgrades: Boston Scientific Flashes Improved Price Strength

A Relative Strength Rating upgrade for Boston Scientific shows improving technical performance. Will it continue?

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Boston Scientific At The Starting Line Again After Its Stock Hits A Record High, Consolidates.

Boston Scientific shows rising price performance, earning an upgrade to its IBD Relative Strength Rating.

Investors Business Daily

Boston Scientific Reports 16 Deaths Linked To Defibrillator Lead Issue

The Food and Drug Administration (FDA) said on Wednesday it is monitoring a potential safety issue involving Boston Scientific Corporation’s (NYSE:BSX) ENDOTAK RELIANCE defibrillation leads, following a letter from the company alerting healthcare providers of possible reduced shock efficacy.

Benzinga

FDA flags problems with two Boston Scientific heart devices tied to injuries and deaths

U.S. health officials have issued warnings on two separate Boston Scientific heart devices recently linked to injuries and deaths

The Independent UK

Stock Market Keeps Hitting Highs Amid Tesla, Google, Trade Deals: Weekly Review

The S&P 500 and Nasdaq hit fresh highs last week, aided by Trump trade deals. Google, ServiceNow and GE Vernova were earnings winners. Tesla tumbled.

Investors Business Daily

Boston Scientific Reports Higher Profit Margins In Q2, Lifts Guidance

Stronger‑than‑expected sales and raised full‑year guidance underscore Boston Scientific Corporation‘s (NYSE:BSX) momentum—and hint at where its next product wins may come.

Benzinga

Boston Scientific Breaks Out As One Key Product Delivers 117% Growth

Boston Scientific stock broke out Wednesday, helped by a strong second-quarter report on the back of its high-profile cardiovascular segment.

Investors Business Daily

Stock Market Today: Dow Soars 500 Points On Trade Deal Progress; Nvidia Rises As Tesla, Google Results Loom (Live Coverage)

The Dow Jones index climbed Wednesday after Trump announced a trade deal with Japan.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

How Unusual Options Standout Boston Scientific (BSX) is Signaling a Statistical Edge

BSX stock may extend its solid performance as options activity and historical patterns suggest a bullish setup with favorable short-term odds.

Barchart

What to Expect From Boston Scientific's Next Quarterly Earnings Report

Boston Scientific is set to announce its second-quarter results later this month, and analysts anticipate double-digit earnings growth.

Barchart

How Is Boston Scientific's Stock Performance Compared to Other Medical Device Stocks?

Due to Boston Scientific's strong performance relative to its industry peers over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

Investors Business Daily

Michael Mahoney Turned Boston Scientific Into A Medical Tech Empire

Michael Mahoney's grandfather was a cardiac surgeon — so his first career plan was to become a doctor. Mahoney didn't give up — he adjusted.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

How Boston Scientific's Surprise Setback Bolstered Two Of Its Top Rivals

Edwards Lifesciences stock jumped Wednesday after Boston Scientific said it would stop selling its rival heart-valve replacement systems.

Investors Business Daily

Two S&P 500 Giants And Tesla's Main Rival Lead 5 Stocks In Buy Areas

The stock market has entered a power trend.

Investors Business Daily

Dow Jones Futures Rise With Inflation Data Due; Tesla Rival Leads 5 Stocks Near Buy Points

The stock market rally is on the cusp of entering a power trend. Here's what that means. Walmart and a Tesla rival are near buy points.

Investors Business Daily

Boston Scientific Stock Flirts With A Buy Point, Once Again

Boston Scientific stock is wavering around the buy point of a double-bottom base. The company recently raised its 2025 earnings outlook.

Investors Business Daily

Palantir, DoorDash — And This 2024 IPO — Lead Breakout Barrage

Heading a slew of earnings, IBD Leaderboard members Palantir, DoorDash, Uber and Rubrik lead the list of stocks to watch amid a new uptrend.

Barchart

Are Wall Street Analysts Predicting Boston Scientific Stock Will Climb or Sink?

Boston Scientific has outpaced the broader market over the past year and analysts are highly upbeat about its future prospects.

AAP

Women left waiting for share of $405m implant payout

A years-long wait for compensation continues for women injured from pelvic mesh implants with delays blamed on difficulty in obtaining medical records.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Investor Business Daily

1,150 stories

Palantir

1,114 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.